TOH edition: Thursday, 17 September 2026 · Health & Medicine
An Extra Seven Months With the People They Love: England Approves Life-Extending Breast Cancer Treatment
Reported by BBC News
Publisher date:
NHS England has approved the breast cancer drug Enhertu, providing thousands of patients with advanced HER2-low and HER2-positive diagnoses access to a therapy proven to extend survival by an average of seven months. The decision follows determined advocacy from patients and clinicians after the treatment was previously accessible in Scotland. Those added months offer families invaluable shared milestones and precious time together.
Seven additional months means irreplaceable family milestones, proving that sustained community and clinician advocacy can dismantle bureaucratic obstacles to life-extending care.
Read the original report at BBC News (opens in a new tab) →
Read the full front page of Thursday, 17 September 2026 →
Get tomorrow's front page
Five reasons to believe in progress, delivered once a day.